Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

The impact of disclosing financial ties in research and clinical care: a systematic review.

Licurse A, Barber E, Joffe S, Gross C.

Arch Intern Med. 2010 Apr 26;170(8):675-82. doi: 10.1001/archinternmed.2010.39. Review.

PMID:
20421551
2.

Public disclosure of conflicts of interest: moving the policy debate forward.

Campbell EG.

Arch Intern Med. 2010 Apr 26;170(8):667. doi: 10.1001/archinternmed.2010.27. No abstract available.

PMID:
20421548
3.

Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Kim SY, Millard RW, Nisbet P, Cox C, Caine ED.

J Med Ethics. 2004 Feb;30(1):73-9.

4.

Attitudes of academic and clinical researchers toward financial ties in research: a systematic review.

Glaser BE, Bero LA.

Sci Eng Ethics. 2005 Oct;11(4):553-73. Review.

PMID:
16279755
5.

Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, Vitry AI.

PLoS Med. 2010 Oct 19;7(10):e1000352. doi: 10.1371/journal.pmed.1000352. Review.

6.

Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.

Sah S.

J Law Med Ethics. 2012 Fall;40(3):482-7. doi: 10.1111/j.1748-720X.2012.00680.x.

PMID:
23061575
7.

Why academic medical centers should ban drug company gifts to individuals.

Strong C.

Am J Bioeth. 2010 Jan;10(1):13-5. doi: 10.1080/15265160903441061. No abstract available.

PMID:
20077327
8.

Patients' attitudes about gifts to physicians from pharmaceutical companies.

Blake RL Jr, Early EK.

J Am Board Fam Pract. 1995 Nov-Dec;8(6):457-64.

PMID:
8585404
9.
10.

Patients' views on financial conflicts of interest in cancer research trials.

Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ.

N Engl J Med. 2006 Nov 30;355(22):2330-7.

11.

Research funding, conflicts of interest, and the meta-methodology of public relations.

Rampton S, Stauber J.

Public Health Rep. 2002 Jul-Aug;117(4):331-9. No abstract available.

12.
13.

Conflicts of interest in pain medicine: Practice patterns and relationships with industry.

Schofferman J, Banja J.

Pain. 2008 Oct 31;139(3):494-7. doi: 10.1016/j.pain.2008.08.016. Epub 2008 Sep 24. Review. No abstract available.

PMID:
18814969
14.
15.

Contact with pharmaceutical representatives: where does prudence lead?

Appelbaum PS.

Am J Bioeth. 2010 Jan;10(1):11-3. doi: 10.1080/15265160903441046. No abstract available.

PMID:
20077326
16.

Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.

Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J.

Psychother Psychosom. 2009;78(4):228-32. doi: 10.1159/000214444. Epub 2009 Apr 28.

PMID:
19401623
17.

Disclosure of competing financial interests and role of sponsors in phase III cancer trials.

Tuech JJ, Moutel G, Pessaux P, Thoma V, Schraub S, Herve C.

Eur J Cancer. 2005 Oct;41(15):2237-40. Epub 2005 Apr 14.

PMID:
16214044
18.
19.

Patient perceptions of physician acceptance of gifts from the pharmaceutical industry.

Mainous AG 3rd, Hueston WJ, Rich EC.

Arch Fam Med. 1995 Apr;4(4):335-9.

PMID:
7711920
20.

Financial disclosures in clinical practice guidelines.

Kahn JM, Rubenfeld GD.

Crit Care Med. 2010 Aug;38(8):1755-6; discussion 1756-7. doi: 10.1097/CCM.0b013e3181de19d9. No abstract available.

PMID:
20647810
Items per page

Supplemental Content

Write to the Help Desk